OxThera Company
OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
Technology:
Others
Industry:
PharmTech
Headquarters:
Stockholm, Stockholms Lan, Sweden
Founded Date:
2005
Employees Number:
11-50
Funding Status:
Late Stage Venture
Investors Number:
10
Total Funding:
€4.9M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Seed
Register and Claim Ownership